¸Þ´º°æ·Î ¹æÇâ Ç¥½Ã
  • ·Î±×ÀÎ
  • Àüü¸Þ´º

ÀÚµ¿·Î±×¾Æ¿ô¾È³»

ÀÚµ¿ ·Î±×¾Æ¿ô ³²Àº ½Ã°£ : 30ÃÊ

°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼­ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µË´Ï´Ù. ·Î±×ÀÎ ½Ã°£À» ¿¬ÀåÇϽðڽÀ´Ï±î?

ÀÚµ¿·Î±×¾Æ¿ô¾È³»

°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼­ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µÇ¾ú½À´Ï´Ù.

±¹Á¦Çмú ½ÉÆ÷Áö¾ö

Home > ÀÇ·á¿øPR > ±¹Á¦Çмú ½ÉÆ÷Áö¾ö
  • Á¦9ȸ ÇѸ²-¿ó»ì¶ó ±¹Á¦Çмú ½ÉÆ÷Áö¾ö
    (½ÉÇ÷°ü ÁúȯÀÇ »õ·Î¿î Á¢±Ù)

³»¿ë


    • Çà»ç¸í : Á¦9ȸ ÇѸ²-¿ó»ì¶ó ±¹Á¦Çмú ½ÉÆ÷Áö¾ö
                  The 9th Hallym-Uppsala International Symposium

    • ÁÖÁ¦ : ½ÉÇ÷°ü ÁúȯÀÇ »õ·Î¿î Á¢±Ù
               Novel Approaches in Cardiovascular Disease

    • ÀϽà : 2017³â 9¿ù 19ÀÏ (È­) 09:50 – 17:00

    • Àå¼Ò : ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ´ë°­´ç(4Ãþ)

    • ÁÖÃÖ : ÇѸ²´ëÇб³ÀÇ·á¿ø

    • ÆòÁ¡ : ´ëÇÑÀÇ»çÇùȸ 5ÆòÁ¡, ´ëÇѳ»°úÇÐȸ ¼øȯ±âºÐ°ú Àü¹®ÀÇ ¿¬¼ö±³À° 5ÆòÁ¡

    • »çÀüµî·Ï : ¿Â¶óÀÎ »çÀüµî·Ï(2017. 7. 20 ~ 9. 12)

    • ¹®ÀÇ : ÇѸ²´ëÇб³ÀÇ·á¿ø ±¹Á¦±³·ùÆÀ (Tel. 02-2629-1272 e-mail. international@hallym.or.kr)

    • ÇÁ·Î±×·¥



      ½Ã°£³»¿ë
      09:00µî·Ï
      09:50 - 10:00°³È¸½Ä
      Session 1

      Chairs: Agneta Siegbahn(¿ó»ì¶ó´ë) & È«°æ¼ø(ÇѸ²ÀÇ´ë)

      10:00 - 10:30

      Micro RNA, extracellular vesicles and novel biomarker methods in cardiovascular disease
      ½ÉÇ÷°ü Áúȯ¿¡¼­ÀÇ Micro RNA, ¼¼Æ÷¿Ü ¼ÒÆ÷ü ±×¸®°í »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿

      - Agneta Siegbahn(¿ó»ì¶ó´ë)

      10:30 - 10:50

      Unmet needs in the management of acute myocardial infarction: from pharmacodynamic perspectives
      ±Þ¼º½É±Ù°æ»öÁõ ȯÀÚ¿¡¼­ Ç×Ç÷Àü Ä¡·áÀÇ ³­Á¦µé°ú ÇØ°á¹æ¾È - ¾àµ¿ÇÐÀû °üÁ¡¿¡¼­

      - Á¶Á¤·¡(ÇѸ²ÀÇ´ë)

      10:50 - 11:20

      Clinical utility of biomarkers in cardiovascular disease
      ½ÉÇ÷°ü Áúȯ¿¡¼­ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ÀÓ»óÀû À¯¿ë¼º

      - Claes Held(¿ó»ì¶ó´ë)

      11:20 - 11:40

      Clinical meaning of vasa vasorum: from early atherosclerosis to the vulnerable plaque
      ¸Æ°üÀÇ ÀÓ»óÀû ÀÇÀÇ: Ãʱ⠵¿¸Æ°æÈ­ºÎÅÍ ºÒ¾ÈÁ¤ Á×»ó¹Ý±îÁö

      - ¹Ú°æÇÏ(ÇѸ²ÀÇ´ë)

      11:40 - 12:00

      Discussion
      ÆгΠ: ±èÀÀÁÖ(°í·ÁÀÇ´ë), ÀÌÇØ¿µ(¼­¿ïÀÇ´ë)

      12:00 - 13:20Lunch
      Session 2

      Chairs: Jonas Oldgren(¿ó»ì¶ó´ë) & Á¶¸íÂù(ÃæºÏÀÇ´ë)

      13:20 - 13:50

      New concept for pragmatic clinical trials in cardiovascular disease
      ½ÉÇ÷°ü Áúȯ¿¡¼­ ½Ç¿ëÀû ÀÓ»ó ¿¬±¸ÀÇ »õ·Î¿î °³³ä

      - Jonas Oldgren(¿ó»ì¶ó´ë)

      13:50 - 14:10

      Acute heart failure in Korea: Focused on temporal trends
      Çѱ¹ÀÎ ±Þ¼º ½ÉºÎÀüÀÇ Æ¯Â¡ (½Ã±âº° Ãß¼¼¸¦ Áß½ÉÀ¸·Î)

      - À±Á¾Âù(ÇѸ²ÀÇ´ë)

      14:10 - 14:30

      Hypertension in Korea: Focused on age and subclinical target organ damages
      Çѱ¹ÀÎ °íÇ÷¾ÐÀÇ Æ¯Â¡ (¿¬·É ¹× Ç¥Àû Àå±â ¼Õ»óÀ» Áß½ÉÀ¸·Î)

      - ÃÖ¼®¿ø(ÇѸ²ÀÇ´ë)

      14:30 - 14:50

      Discussion
      ÆгΠ: °­¼®¹Î(¿¬¼¼ÀÇ´ë), Á¤¿íÁø(°¡ÃµÀÇ´ë)

      14:50 - 15:10Coffee Break

      -

      Chairs: ÀüÀº¼®(¼º±Õ°üÀÇ´ë) & À̳²È£(ÇѸ²ÀÇ´ë)

      15:10 - 15:40

      Real world evidence confirming results from clinical trials
      ÀÓ»ó ½ÃÇè °á°ú¸¦ È®ÀÎÇÏ´Â ½ÇÁ¦ Áø·á ÇöÀå¿¡¼­ÀÇ ±Ù°Å

      - Claes Held(¿ó»ì¶ó´ë)

      15:40 - 16:00

      Acute myocardial infarction in Korea: Focused on current treatment and outcomes
      Çѱ¹ÀÎ ±Þ¼º½É±Ù°æ»öÁõ ȯÀÚÀÇ Ä¡·á ÇöȲ°ú ¼ºÀû

      - Á¶»óÈ£(ÇѸ²ÀÇ´ë)

      16:00 - 16:20

      Peripartum cardiomyopathy in Korea: Focused on prevalence and risk factors
      ºòµ¥ÀÌÅ͸¦ È°¿ëÇÑ ±¹³» ÁÖ»ê±â ½É±ÙÁõÀÇ ¹ß»ý·ü ¹× °ü·ÃµÈ À§ÇèÀÎÀÚ ÆľÇ

      - À̼±±â(ÇѸ²ÀÇ´ë)

      16:20 - 16:40

      Discussion
      ÆгΠ: ±èÀçÁß(¿ï»êÀÇ´ë), ÃÖµ¿ÁÖ(¼­¿ïÀÇ´ë)

      16:40 - 17:00

      Æóȸ½Ä